218 related articles for article (PubMed ID: 37178478)
1. Cell-permeable chameleonic peptides: Exploiting conformational dynamics in de novo cyclic peptide design.
Ramelot TA; Palmer J; Montelione GT; Bhardwaj G
Curr Opin Struct Biol; 2023 Jun; 80():102603. PubMed ID: 37178478
[TBL] [Abstract][Full Text] [Related]
2. Solution Conformations Explain the Chameleonic Behaviour of Macrocyclic Drugs.
Danelius E; Poongavanam V; Peintner S; Wieske LHE; Erdélyi M; Kihlberg J
Chemistry; 2020 Apr; 26(23):5231-5244. PubMed ID: 32027758
[TBL] [Abstract][Full Text] [Related]
3. Passing the Barrier - How Computer Simulations Can Help to Understand and Improve the Passive Membrane Permeability of Cyclic Peptides.
Linker SM; Wang S; Ries B; Stadelmann T; Riniker S
Chimia (Aarau); 2021 Jun; 75(6):518-521. PubMed ID: 34233816
[TBL] [Abstract][Full Text] [Related]
4. Targeting intracellular protein-protein interactions with cell-permeable cyclic peptides.
Qian Z; Dougherty PG; Pei D
Curr Opin Chem Biol; 2017 Jun; 38():80-86. PubMed ID: 28388463
[TBL] [Abstract][Full Text] [Related]
5. Controlling the Chameleonic Behavior and Membrane Permeability of Cyclosporine Derivatives via Backbone and Side Chain Modifications.
Lee D; Choi J; Yang MJ; Park CJ; Seo J
J Med Chem; 2023 Sep; 66(18):13189-13204. PubMed ID: 37718494
[TBL] [Abstract][Full Text] [Related]
6. Conformation and Permeability: Cyclic Hexapeptide Diastereomers.
Ono S; Naylor MR; Townsend CE; Okumura C; Okada O; Lokey RS
J Chem Inf Model; 2019 Jun; 59(6):2952-2963. PubMed ID: 31042375
[TBL] [Abstract][Full Text] [Related]
7. Membrane Permeability in Cyclic Peptides is Modulated by Core Conformations.
Cipcigan F; Smith P; Crain J; Hogner A; De Maria L; Llinas A; Ratkova E
J Chem Inf Model; 2021 Jan; 61(1):263-269. PubMed ID: 33350828
[TBL] [Abstract][Full Text] [Related]
8. Polar/apolar interfaces modulate the conformational behavior of cyclic peptides with impact on their passive membrane permeability.
Linker SM; Schellhaas C; Ries B; Roth HJ; Fouché M; Rodde S; Riniker S
RSC Adv; 2022 Feb; 12(10):5782-5796. PubMed ID: 35424539
[TBL] [Abstract][Full Text] [Related]
9. cis-Peptide Bonds: A Key for Intestinal Permeability of Peptides? .
Marelli UK; Ovadia O; Frank AO; Chatterjee J; Gilon C; Hoffman A; Kessler H
Chemistry; 2015 Oct; 21(43):15148-52. PubMed ID: 26337831
[TBL] [Abstract][Full Text] [Related]
10. Effect of Flexibility, Lipophilicity, and the Location of Polar Residues on the Passive Membrane Permeability of a Series of Cyclic Decapeptides.
Wang S; König G; Roth HJ; Fouché M; Rodde S; Riniker S
J Med Chem; 2021 Sep; 64(17):12761-12773. PubMed ID: 34406766
[TBL] [Abstract][Full Text] [Related]
11. Cyclic Peptides as Drugs for Intracellular Targets: The Next Frontier in Peptide Therapeutic Development.
Buckton LK; Rahimi MN; McAlpine SR
Chemistry; 2021 Jan; 27(5):1487-1513. PubMed ID: 32875673
[TBL] [Abstract][Full Text] [Related]
12. Lessons for Oral Bioavailability: How Conformationally Flexible Cyclic Peptides Enter and Cross Lipid Membranes.
Linker SM; Schellhaas C; Kamenik AS; Veldhuizen MM; Waibl F; Roth HJ; Fouché M; Rodde S; Riniker S
J Med Chem; 2023 Feb; 66(4):2773-2788. PubMed ID: 36762908
[TBL] [Abstract][Full Text] [Related]
13. Cell-permeable cyclic peptides from synthetic libraries inspired by natural products.
Hewitt WM; Leung SS; Pye CR; Ponkey AR; Bednarek M; Jacobson MP; Lokey RS
J Am Chem Soc; 2015 Jan; 137(2):715-21. PubMed ID: 25517352
[TBL] [Abstract][Full Text] [Related]
14. Accurate de novo design of membrane-traversing macrocycles.
Bhardwaj G; O'Connor J; Rettie S; Huang YH; Ramelot TA; Mulligan VK; Alpkilic GG; Palmer J; Bera AK; Bick MJ; Di Piazza M; Li X; Hosseinzadeh P; Craven TW; Tejero R; Lauko A; Choi R; Glynn C; Dong L; Griffin R; van Voorhis WC; Rodriguez J; Stewart L; Montelione GT; Craik D; Baker D
Cell; 2022 Sep; 185(19):3520-3532.e26. PubMed ID: 36041435
[TBL] [Abstract][Full Text] [Related]
15. Conformational Flexibility Is a Determinant of Permeability for Cyclosporin.
Wang CK; Swedberg JE; Harvey PJ; Kaas Q; Craik DJ
J Phys Chem B; 2018 Mar; 122(8):2261-2276. PubMed ID: 29400464
[TBL] [Abstract][Full Text] [Related]
16. Highly Conformationally Restricted Cyclopropane Tethers with Three-Dimensional Structural Diversity Drastically Enhance the Cell Permeability of Cyclic Peptides.
Matsui K; Kido Y; Watari R; Kashima Y; Yoshida Y; Shuto S
Chemistry; 2017 Mar; 23(13):3034-3041. PubMed ID: 27878880
[TBL] [Abstract][Full Text] [Related]
17. CycPeptMPDB: A Comprehensive Database of Membrane Permeability of Cyclic Peptides.
Li J; Yanagisawa K; Sugita M; Fujie T; Ohue M; Akiyama Y
J Chem Inf Model; 2023 Apr; 63(7):2240-2250. PubMed ID: 36930969
[TBL] [Abstract][Full Text] [Related]
18. Flexibility versus Rigidity for Orally Bioavailable Cyclic Hexapeptides.
Nielsen DS; Lohman RJ; Hoang HN; Hill TA; Jones A; Lucke AJ; Fairlie DP
Chembiochem; 2015 Nov; 16(16):2289-93. PubMed ID: 26336864
[TBL] [Abstract][Full Text] [Related]
19. Macrocyclic Peptides as Drug Candidates: Recent Progress and Remaining Challenges.
Vinogradov AA; Yin Y; Suga H
J Am Chem Soc; 2019 Mar; 141(10):4167-4181. PubMed ID: 30768253
[TBL] [Abstract][Full Text] [Related]
20. Design Principles for Intestinal Permeability of Cyclic Peptides.
Mathiowetz AM
Methods Mol Biol; 2019; 2001():1-15. PubMed ID: 31134564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
